High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019

The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly in China. Until now, no definite effective treatment has been identified. We reported on 3 patients with severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observat...

Full description

Saved in:
Bibliographic Details
Published in:Open forum infectious diseases 2020-03, Vol.7 (3), p.ofaa102-ofaa102
Main Authors: Cao, Wei, Liu, Xiaosheng, Bai, Tao, Fan, Hongwei, Hong, Ke, Song, Hui, Han, Yang, Lin, Ling, Ruan, Lianguo, Li, Taisheng
Format: Article
Language:English
Subjects:
Brief Report
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly in China. Until now, no definite effective treatment has been identified. We reported on 3 patients with severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observations, randomized studies of high-dose IVIg should be considered in deteriorating patients infected with COVID-19.
ISSN:2328-8957
2328-8957
DOI:10.1093/ofid/ofaa102